BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sirion Therapeutics 

3110 Cherry Palm Drive
Suite 340
Tampa  Florida  33619  U.S.A.
Phone: 813-496-7325 Fax: 813-496-7328


SEARCH JOBS




Industry
Diagnostics

Segment
Start Up





 Company News
Sirion Therapeutics U.S. Rights for Eye Treatment to Bausch & Lomb (BOL) 6/3/2010 8:15:01 AM
Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 4/26/2010 8:47:09 AM
Alcon, Inc. (ACL) Completes Acquisition of DUREZOL(TM) and ZYCLORIN(TM) from Sirion Therapeutics 3/30/2010 8:50:16 AM
Alcon, Inc. (ACL) to Purchase Ophthalmic Pharmaceutical Assets from Sirion Therapeutics 1/19/2010 10:36:37 AM
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) 0.15% for Herpetic Keratitis Zirgan 9/16/2009 8:46:48 AM
Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology Annual Meeting 4/30/2009 12:15:20 PM
Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide 4/15/2009 8:23:29 AM
Sirion Therapeutics Supplemental New Drug Application for Durezol(TM) to Treat Uveitis is Accepted for Review by the FDA 3/16/2009 9:59:58 AM
Sirion Therapeutics Partners With Advanced Vision Research to Promote Products for Retinal and Meibomian Gland Health 2/17/2009 8:54:44 AM
Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes 1/26/2009 9:57:07 AM
123